4gqb
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Crystal Structure of the human PRMT5:MEP50 Complex== | ==Crystal Structure of the human PRMT5:MEP50 Complex== | ||
- | <StructureSection load='4gqb' size='340' side='right' caption='[[4gqb]], [[Resolution|resolution]] 2.06Å' scene=''> | + | <StructureSection load='4gqb' size='340' side='right'caption='[[4gqb]], [[Resolution|resolution]] 2.06Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4gqb]] is a 3 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4gqb]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4GQB OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4GQB FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=0XU:(2S,5S,6E)-2,5-DIAMINO-6-[(3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXYDIHYDROFURAN-2(3H)-YLIDENE]HEXANOIC+ACID'>0XU</scene> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=0XU:(2S,5S,6E)-2,5-DIAMINO-6-[(3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXYDIHYDROFURAN-2(3H)-YLIDENE]HEXANOIC+ACID'>0XU</scene>, <scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene></td></tr> |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4gqb FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4gqb OCA], [https://pdbe.org/4gqb PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4gqb RCSB], [https://www.ebi.ac.uk/pdbsum/4gqb PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4gqb ProSAT]</span></td></tr> | |
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/ANM5_HUMAN ANM5_HUMAN] Arginine methyltransferase that can both catalyze the formation of omega-N monomethylarginine (MMA) and symmetrical dimethylarginine (sDMA), with a preference for the formation of MMA. Specifically mediates the symmetrical dimethylation of arginine residues in the small nuclear ribonucleoproteins Sm D1 (SNRPD1) and Sm D3 (SNRPD3); such methylation being required for the assembly and biogenesis of snRNP core particles. Methylates SUPT5H. Mono- and dimethylates arginine residues of myelin basic protein (MBP) in vitro. Plays a role in the assembly of snRNP core particles. May play a role in cytokine-activated transduction pathways. Negatively regulates cyclin E1 promoter activity and cellular proliferation. May regulate the SUPT5H transcriptional elongation properties. May be part of a pathway that is connected to a chloride current, possibly through cytoskeletal rearrangement. Methylates histone H2A and H4 'Arg-3' during germ cell development. Methylates histone H3 'Arg-8', which may repress transcription. Methylates the Piwi proteins (PIWIL1, PIWIL2 and PIWIL4), methylation of Piwi proteins being required for the interaction with Tudor domain-containing proteins and subsequent localization to the meiotic nuage. Methylates RPS10. Attenuates EGF signaling through the MAPK1/MAPK3 pathway acting at 2 levels. First, monomethylates EGFR; this enhances EGFR 'Tyr-1197' phosphorylation and PTPN6 recruitment, eventually leading to reduced SOS1 phosphorylation. Second, methylates RAF1 and probably BRAF, hence destabilizing these 2 signaling proteins and reducing their catalytic activity. Required for induction of E-selectin and VCAM-1, on the endothelial cells surface at sites of inflammation. Methylates HOXA9. Methylates and regulates SRGAP2 which is involved in cell migration and differentiation. Acts as a transcriptional corepressor in CRY1-mediated repression of the core circadian component PER1 by regulating the H4R3 dimethylation at the PER1 promoter.<ref>PMID:10531356</ref> <ref>PMID:11152681</ref> <ref>PMID:11747828</ref> <ref>PMID:12411503</ref> <ref>PMID:15737618</ref> <ref>PMID:17709427</ref> <ref>PMID:20159986</ref> <ref>PMID:20810653</ref> <ref>PMID:21258366</ref> <ref>PMID:21917714</ref> <ref>PMID:22269951</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 22: | Line 20: | ||
==See Also== | ==See Also== | ||
- | *[[Histone methyltransferase|Histone methyltransferase]] | + | *[[Histone methyltransferase 3D structures|Histone methyltransferase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: Antonysamy | + | [[Category: Large Structures]] |
- | [[Category: Bonday | + | [[Category: Antonysamy S]] |
- | [[Category: Campbell | + | [[Category: Bonday Z]] |
- | [[Category: Doyle | + | [[Category: Campbell R]] |
- | [[Category: Druzina | + | [[Category: Doyle B]] |
- | [[Category: Emtage | + | [[Category: Druzina Z]] |
- | [[Category: Gheyi | + | [[Category: Emtage S]] |
- | [[Category: Han | + | [[Category: Gheyi T]] |
- | [[Category: Jungheim | + | [[Category: Han B]] |
- | [[Category: Qian | + | [[Category: Jungheim LN]] |
- | [[Category: Rauch | + | [[Category: Qian Y]] |
- | [[Category: Russell | + | [[Category: Rauch C]] |
- | [[Category: Sauder | + | [[Category: Russell M]] |
- | [[Category: Wasserman | + | [[Category: Sauder JM]] |
- | [[Category: Weichert | + | [[Category: Wasserman SR]] |
- | [[Category: Willard | + | [[Category: Weichert K]] |
- | [[Category: Zhang | + | [[Category: Willard FS]] |
- | + | [[Category: Zhang A]] | |
- | + | ||
- | + | ||
- | + | ||
- | + |
Revision as of 07:10, 26 October 2022
Crystal Structure of the human PRMT5:MEP50 Complex
|
Categories: Homo sapiens | Large Structures | Antonysamy S | Bonday Z | Campbell R | Doyle B | Druzina Z | Emtage S | Gheyi T | Han B | Jungheim LN | Qian Y | Rauch C | Russell M | Sauder JM | Wasserman SR | Weichert K | Willard FS | Zhang A